Impact of Platelet Volume on the Clinical Outcomes of Patients with Acute Coronary Syndrome

被引:9
作者
Chang, Hsien-Yuan [1 ,2 ,3 ]
Hsu, Ling-Wei [4 ]
Lee, Cheng-Han [2 ]
Lin, Chih-Chan [2 ]
Huang, Chen-Wei [2 ]
Chen, Po-Wei [2 ]
Yang, Po-Kai [1 ,2 ]
Hsueh, Yang-Che [1 ]
Liu, Ping-Yen [2 ,3 ]
机构
[1] Natl Cheng Kung Univ Hosp, Douliou Branch, Dept Internal Med, Div Cardiol, Yunlin, Taiwan
[2] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Internal Med,Div Cardiol, Tainan, Taiwan
[3] Natl Cheng Kung Univ, Coll Medline, Inst Clin Med, Tainan, Taiwan
[4] Natl Cheng Kung Univ, Coll Medline, Inst Basic Med Sci, Tainan, Taiwan
关键词
Acute coronary syndrome; ACS; Mean platelet volume; MPV; INFLAMMATORY RESPONSE; DISEASE; ACTIVATION; THROMBOSIS; PREDICTOR; MORTALITY; PROFILE; SIZE;
D O I
10.6515/ACS.201911_35(6).20190423B
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Platelets with high hemostatic activity play an important role in the pathophysiology of acute coronary syndrome (ACS), and mean platelet volume (MPV) has been proposed to be an indicator of platelet reactivity. We evaluated the predictive value of MPV and the responsive value of MPV with different antiplatelet agents in association with the clinical outcomes of ACS patients. Methods: A total of 1094 patients with ACS and 472 patients without ACS were included. Blood samples were taken at hospital admission, at routine follow-up within one year, and beyond one year. The patients were divided into a "high MPV group" (> 9.0 fl, n = 305), "medium MPV group" (7.9-9.0 fl, n = 517), and "low MPV group" (< 7.9 fl, n = 272). The average follow-up time was 2.4 years, and the endpoints were major adverse cardiovascular events (MACEs) including all-cause mortality, time to recurrent ACS, target vessel re-intervention and stroke. Results: MPV was significantly higher in the patients with ACS than in those without ACS (8.6 +/- 1.1 vs. 8.4 +/- 1.0 fl, p = 0.007). MPV decreased in the following year (8.38 +/- 1.02 fl, p < 0.001) and also beyond one year (8.38 +/- 0.94 fl, p < 0.001) after ACS events. The changes in MPV were not significantly different between the patients receiving either clopidogrel or ticagrelor. The high MPV group had more cardiovascular risk factors and more MACEs than the low MPV group (p = 0.017). Conclusions: A higher MPV in patients with ACS was associated with more cardiovascular risk factors and more cardiovascular events during clinical follow-up.
引用
收藏
页码:563 / 570
页数:8
相关论文
共 50 条
  • [41] Impact of Vitamin D Supplementation on the Clinical Outcomes and Epigenetic Markers in Patients with Acute Coronary Syndrome
    Sarhan, Neven
    Abou Warda, Ahmed Essam
    Alsahali, Saud
    Alanazi, Abdalla Salah
    PHARMACEUTICALS, 2023, 16 (02)
  • [42] Impact of triage nurses' recognition of acute coronary syndrome on patients' clinical outcomes: A retrospective study
    Alsharawneh, Anas
    Sawalha, Murad
    Abu Tabar, Nazih
    Elshatarat, Rami A.
    Almarwani, Abdulaziz Mofdy
    Saleh, Zyad T.
    Almagharbeh, Wesam T.
    Al-Akash, Hekmat Y.
    Mohamed, Nermen A.
    Eltayeb, Mudathir M.
    HEART & LUNG, 2024, 68 : 60 - 67
  • [43] Relation Between Mean Platelet Volume and Severity of Atherosclerosis in Patients With Acute Coronary Syndromes
    Murat, Sani Namik
    Duran, Mustafa
    Kalay, Nihat
    Gunebakmaz, Ozgur
    Akpek, Mahmut
    Doger, Cihan
    Elcik, Deniz
    Ocak, Ayse
    Vatankulu, Mehmet Akif
    Turfan, Murat
    Kasapkara, Haci Ahmet
    Akin, Fatih
    Sahin, Musa
    Kaya, Mehmet Gungor
    ANGIOLOGY, 2013, 64 (02) : 131 - 136
  • [44] Mean Platelet Volume on Admission Improves Risk Prediction in Patients With Acute Coronary Syndromes
    Niu, Xiaowei
    Yang, Cuiling
    Zhang, Yiming
    Zhang, Hengliang
    Yao, Yali
    ANGIOLOGY, 2015, 66 (05) : 456 - 463
  • [45] Impact of malignancy on clinical outcomes in patients with acute coronary syndromes
    Yousif, Nooraldaem
    Niederseer, David
    Davies, Allan
    El Issa, Meidi
    Sidia, Besma
    Noor, Husam A.
    Amin, Haitham
    Raber, Lorenz
    Gencer, Baris
    Klingenberg, Roland
    Windecker, Stephan
    Mach, Francois
    Matter, Christian M.
    Nanchen, David
    Luscher, Thomas F.
    Obeid, Slayman
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 328 : 8 - 13
  • [46] On-Ticagrelor Platelet Reactivity and Clinical Outcome in Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome
    Laine, Marc
    Panagides, Vassili
    Frere, Corinne
    Cuisset, Thomas
    Gouarne, Caroline
    Jouve, Bernard
    Lemesle, Gilles
    Paganelli, Franck
    Alessi, Marie-Christine
    Mancini, Julien
    Bonello, Laurent
    THROMBOSIS AND HAEMOSTASIS, 2021, 121 (07) : 923 - 930
  • [47] Outcomes among patients with coronary artery bypass grafts presenting with acute coronary syndrome: impact of revascularization
    Bews, Hilary J.
    Hiebert, Brett
    Liu, Shuangbo
    Ducas, John
    Ravandi, Amir
    Minhas, Kunal
    Kass, Malek
    Love, Michael P.
    Wijeysundera, Harindra C.
    Shah, Ashish H.
    THERAPEUTIC ADVANCES IN CARDIOVASCULAR DISEASE, 2025, 19
  • [48] The Impact of FEV1/FVC Ratio on the Clinical Outcomes in Acute Coronary Syndrome Patients Treated with Dual Anti-Platelet Agents
    Yeh, Chia-Hung
    Chung, Wen-Jung
    Chen, Tien-Yu
    Wu, Po-Jui
    Tseng, Chien-Hao
    Lee, Chien-Ho
    Cheng, Cheng-, I
    ACTA CARDIOLOGICA SINICA, 2023, 39 (01) : 116 - 126
  • [49] Inflammatory and Bleeding Risks on Clinical Outcomes in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention
    Duan, Yixuan
    Qiu, Miaohan
    Na, Kun
    Liu, Daoshen
    Zhou, Shangxun
    Xu, Ying
    Qi, Zizhao
    Liu, Haiwei
    Xu, Kai
    Wang, Xiaozeng
    Li, Jing
    Li, Yi
    Han, Yaling
    THROMBOSIS AND HAEMOSTASIS, 2025,
  • [50] Mean Platelet Volume a Risk Indicator in Acute Coronary Syndrome
    Devi, Kannan Meera
    Padma, V
    Sathyapriya
    Shiny, T.
    Sarath
    Saketh
    CARDIOMETRY, 2022, (24): : 1022 - 1027